HOSPIRA INC FDA Approval ANDA 065446

ANDA 065446

HOSPIRA INC

FDA Drug Application

Application #065446

Documents

Letter2009-09-22
Label2009-10-21

Application Sponsors

ANDA 065446HOSPIRA INC

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTIONEQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL0PIPERACILLIN AND TAZOBACTAMPIPERACILLIN SODIUM; TAZOBACTAM SODIUM

FDA Submissions

ORIG1AP2009-09-15
LABELING; LabelingSUPPL3AP2017-12-04
LABELING; LabelingSUPPL7AP2017-12-04STANDARD
LABELING; LabelingSUPPL10AP2017-12-04STANDARD
LABELING; LabelingSUPPL11AP2017-12-04STANDARD
LABELING; LabelingSUPPL13AP2017-12-04STANDARD
LABELING; LabelingSUPPL14AP2017-12-04STANDARD

Submissions Property Types

ORIG1Null3
SUPPL3Null7
SUPPL7Null7
SUPPL10Null7
SUPPL11Null7
SUPPL13Null7
SUPPL14Null7

CDER Filings

HOSPIRA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 65446
            [companyName] => HOSPIRA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"PIPERACILLIN AND TAZOBACTAM","activeIngredients":"PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","strength":"EQ 36GM BASE\/VIAL;EQ 4.5GM BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"09\/15\/2009","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/065446s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"PIPERACILLIN AND TAZOBACTAM","submission":"PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","actionType":"EQ 36GM BASE\/VIAL;EQ 4.5GM BASE\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2009-09-15
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.